Our Services
Clinical Trial Monitoring: Dedicated teams of skilled and well trained clinical research professionals to provide consistent and effective monitoring and interaction with the study sites.
Generic drug development includes conducting Patient PK endpoint studies and also provide support to generic companies for the independent monitoring of the typical BA/BE studies.
PhaseOn’s specialized team can represent sponsors at Clinical Pharmacological Units in India, offering independent monitoring and audit services for BA/BE studies at your chosen CRO.
PhaseOn offers access to highly experienced Quality Assurance personnel to ensure compliance and quality in all clinical studies. We also provide standalone QA and audit support services to clients as needed.
PhaseOn supports generic drug development by conducting Patient PK endpoint studies and offering independent monitoring for BA/BE studies, assisting generic companies throughout the process.
PhaseOn has a dedicated regulatory affairs team that ensures smooth clinical trial approvals by effectively liaising with regulatory agencies and guiding accurate, compliant drug development processes.
PhaseOn has a dedicated team of medical and therapeutic experts conducting feasibility assessments prior to study initiation, ensuring informed planning and optimized study execution.
PhaseOn leverages robust feasibility data and a trusted network of ICH-GCP trained KOLs and investigators across India to ensure accurate site selection across therapeutic areas.
PhaseOn excels in drug storage, distribution, and logistics—critical components of clinical trial success—offering reliable, proven solutions tailored to client needs.
At PhaseOn, we prioritize data integrity. Our experts collaborate from study initiation to ensure a high-quality Data Management Plan, covering Data Management, Biostatistics, and Medical Writing, including final CSR development.
PhaseOn fosters a culture of continuous learning, offering customized training in Advanced GCP, Therapeutic Areas, and Regulatory Trends for CRAs, while also extending these programs to professionals from pharma companies and CROs.
PhaseOn’s experts provide guidance on regulatory pathways, offering consultation on clinical development, dossier preparation, and submissions, while our strong networks enable timely responses to regulatory authority queries across regions.